Last updated 2026-06-18
- Acquired by Phibro Animal Health, Dec 2018
Total raised
—
Stage
Acquired
Founded
2003
Headcount
6
HQ
Jerusalem, Israel
Sector
—
About
KoVax develops and manufactures aquaculture vaccines for viral and bacterial diseases and provides diagnostic services for all stages of fish growth. KoVax produces and markets autogenous vaccines for bacterial diseases, including the patented CyHV3 (KHV) vaccine and KV3 for koi and common carp. KV3 is a patent that KoVax acquired from the Hebrew University and the Israeli Ministry of Agriculture. The company has also developed a vaccine against TLV (TiLV).
Q&A
- What is KoVax's primary focus?
- KoVax develops and manufactures aquaculture vaccines for viral and bacterial diseases in fish and provides diagnostic services.
- When was KoVax founded?
- KoVax was founded in March 2003.
- What is the current status of KoVax?
- KoVax was acquired by Phibro Animal Health in December 2018 and is currently inactive.
- What specific vaccines does KoVax produce?
- KoVax produces autogenous vaccines for bacterial diseases, including the patented CyHV3 (KHV) vaccine and KV3 for koi and common carp. The company has also developed a vaccine against TLV (TiLV).
- From whom did KoVax acquire the KV3 patent?
- KoVax acquired the KV3 patent from the Hebrew University and the Israeli Ministry of Agriculture.
- Who is a founder of KoVax?
- Orit Kotler is a co-founder and CEO of KoVax.
- In which sector does KoVax operate?
- KoVax operates in the Health Tech & Life Sciences, Pharma & Medical Biotechnology, and Drug Delivery sectors.
Team · 1
Sectors & technology
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Biologicals
Target customers
Agriculture & FoodMarine LifeFish
Business model
B2B
Highlights
1 PatentsVerified
Tags
aquaculturepharmaceuticalsveterinarybiotechnologyagtechfish-farmslivestockdisease-managementvaccines
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2003-3 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Acquired (Inactive) by Phibro Animal Health on Dec 2018 - closed due to acquisition |
Acquisitions & public offerings
Acquired by Phibro Animal Health 2018-12
Radar intelligence
Patents
| EPO | 21 |
|---|
Publications (Crossref)
| Works | 3 |
|---|